GALA RENEE D 4
4 · DEXCOM INC · Filed Jun 1, 2026
Research Summary
AI-generated summary of this filing
DexCom (DXCM) Director Gala Renee D Receives RSU Award
What Happened
Gala Renee D, a director of DexCom, Inc. (DXCM), was granted 5,605 restricted stock units (RSUs) on May 28, 2026. The award was reported on a Form 4 filed June 1, 2026. The RSUs were granted at $0.00 (no cash exchanged) and each RSU represents a contingent right to receive one share of DexCom common stock upon settlement.
Key Details
- Transaction date: 2026-05-28 (Grant / Award, code A) — 5,605 RSUs @ $0.00 (value $0 reported)
- Vesting: 100% of the May 28, 2026 RSU award vests on the earlier of the one-year anniversary of the grant or DexCom's 2027 Annual Meeting of Stockholders (Footnote F1).
- Holdings noted: Footnote F2 indicates 9,418 unvested RSUs are included in the reported holdings — 5,605 from this grant and 3,813 from a March 6, 2025 grant that vest through March 6, 2028.
- Filing: Form 4 filed 2026-06-01 for a 2026-05-28 transaction — this appears to be filed after the typical two-business-day reporting window.
- Exhibit: Exhibit 24 (Power of Attorney) included with the filing.
Context
RSUs are a form of equity compensation that convert into shares when they vest and are settled; they do not indicate an immediate purchase or sale. Grants to directors are common as part of compensation and do not by themselves signal a buy/sell decision. This transaction is an award/grant (not a sale), so it is generally treated as routine compensation rather than a direct market signal.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-05-28+5,605→ 12,486 total
Footnotes (2)
- [F1]The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
- [F2]Included in this number are 9,418 unvested restricted stock units, 5,605 of which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders, and 3,813 of which were granted on March 6, 2025 and shall vest through March 6, 2028.